Prehepatic portal hypertension worsens the enterohepatic redox balance in thioacetamide-cirrhotic rats

Pathophysiology

Volumn 15, Issue 4, 2008, Pages 233-242

  Aller, M A ^a   Vara, E ^a   Garcia C ^a   Mendez M ^b   Mendez Lopez M ^b   Mejia I ^a   Lopez L ^b   Arias, J L ^b   Arias, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Catalase; Glutathione peroxidase; Liver cirrhosis; Oxidative stress; Partial portal vein ligation; Portal hypertension; Rat; Superoxide dismutase; Thioacetamide

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENTEROHEPATIC CIRCULATION; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME SYNTHESIS; EXTRAHEPATIC BILE DUCT OBSTRUCTION; ILEUM; LIPID PEROXIDATION; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER TOXICITY; MALE; MESENTERY BLOOD FLOW; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; VEIN LIGATION; WISTAR RAT;

EID: 56649111195     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2008.09.003     Document Type: Article

References (68)

1. Abraldes J.G., Pasarin M., and Garcia-Pagan J.C. Animal models of portal hypertension. World J. Gastroenterol. 12 (2006) 6577-6584
2. Tsai M.-H. Splanchnic and systemic vasodilation. The patient. J. Clin. Gastroenterol. 41 (2007) S266-S271
3. Alonso M.J., Aller M.A., Corcuera M.T., Nava M.P., Gomez F., Angulo A., and Arias J. Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension. Hepatogastroenterology 52 (2005) 541-546
4. Aller M.A., Vara E., García C., Nava M.P., Angulo A., Sánchez-Patan F., Calderon A., Vergara P., and Arias J. Hepatic lipid metabolism changes in short-and long-term prehepatic portal hypertensive rats. World J. Gastroenterol. 14 (2006) 6828-6834
5. Sánchez-Patán F., Anchuelo R., Aller M.A., Vara E., García C., Nava M.P., and Arias J. Chronic prehepatic portal hypertension in the rat: is it a type of metabolic inflammatory syndrome?. Lipids Health Dis. 7 (2008) 4
6. Viggiano T.R., and Gostout C.J. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic and histopathological features. Am. J. Gastroenterol. 87 (1992) 944-954
7. Aller M.A., Nava M.P., Cuellar C., Chivato T., Arias J.L., Sánchez-Patan F., De Vicente F., Alvarez E., and Arias J. Evolutive phases of experimental prehepatic portal hypertension. J. Gastroenterol. Hepatol. 22 (2007) 1127-1155
8. Aller M.A., Arias J.L., and Arias J. The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension. J. Transl. Med. 5 (2007) 44
9. Aller M.A., Arias J.L., Cruz A., and Arias J. Inflammation: a way to understanding the evolution of portal hypertension. Theor. Biol. Med. Model 44 (2007) 44
10. Reddy J.K., and Rao M.S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G852-858
11. Angermayr B., Mejias M., Gracia-Sancho J., Garcia-Pagan J.C., Bosch J., and Fernández M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expresión in portal hypertensive rats. J. Hepatol. 44 (2006) 1033-1039
12. Spitz D.R. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev. 23 (2004) 311-322
13. Chang E.J., and Mun K.C. Effect of melatonin on the malondialdehyde level of neutrophils in cyclosporine-treated rats. Transplant Proc. 36 (2004) 2165-2166
14. Ferré N., and Clária J. New insights into the regulation of liver inflammation and oxidative stress. Mini-Rev. Med. Chem. 6 (2006) 1321-1330
15. Aller M.A., Lorente L., Alonso M.S., and Arias J. A model of cholestasis in the rat using a microsurgical technique. Scand. J. Gastroenterol. 28 (1993) 10-14
16. 4-induced micronodular cirrhosis through enhanced-collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology 34 (2001) 677-687
17. Li X., Benjamin I.S., and Alexander B. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. J. Hepatol. 36 (2002) 488-493
18. Mendez-Lopez M., Mendez M., Sánchez-Patan F., Casado I., Aller M.A., Lopez L., Corcuera M.T., Alonso M.J., Nava M.P., Arias J., and Arias J.L. Partial portal vein ligation plus thioacetamide: a method to obtain a new model of cirrhosis and chronic portal hypertension in the rat. J. Gastrointest. Surg. 11 (2007) 187-194
19. Monterde G., Rodríguez-Fabian G., Vara E., López L., Arias J.L., Aller M.A., and Arias J. Increased plasma levels of corticosterone and prolactin and decreased T3 and T4 levels in short-term prehepatic portal hypertension in rats. Dig. Dis. Sci. 45 (2000) 1865-1871
20. Corcuera M.T., Nava M.P., Angulo A., Aller M.A., Gomez F., Casado I., Alonso M.J., and Arias J. Splanchnic remodeling secondary to experimental prehepatic portal hypertension. An. Med. Int. 22 (2005) 317-322
21. Castañeda B., Dubernardi-Venon W., Bandi J.C., Andreu V., Perez del Pulgar S., Moitinho E., Pizcueta P., and Bosch J. The role of portal pressure in the severity of bleeding in portal hypertensive rats. Hepatology 31 (2000) 581-586
22. Gutteridge J.M.C. Aspects to consider when detecting and measuring lipid peroxidation. Free Radic. Res. Commun. 1 (1986) 173-184
23. Johansson L.H., and Borg L.A.H. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem. 174 (1988) 331-336
24. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
25. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercaptonic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
26. Wheeler C.R., Salzman J.A., Elsayed N.M., et al. automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal. Biochem. 184 (1990) 193-199
27. Hori N., Okanove T., Sawa Y., Mori T., and Kashima K. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. Dig. Dis. Sci. 38 (1993) 2195-2202
28. Yamamoto Y., Yamashita S., Fujisawa A., Kokura S., and Yoshikawa T. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochem. Biophys. Res. Commun. 247 (1998) 166-170
29. Nakata M., Nakamura K., Koda Y., Kaminou T., Ugami M., Kaneda K., and Yamada R. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers. Hepato-Gastroenterology 49 (2002) 652-656
30. Fernández M., Mejias M., Angermayr B., Garcia-Pagan J.C., Rodes J., and Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J. Hepatol. 43 (2005) 98-103
31. Jain S.K. Oxidative stress and metabolic diseases: introduction. Pathophysiology 13 (2006) 127-128
32. Zhang D.X., and Gutterman D.D. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292 (2006) H2023-H2031
33. Conde de la Rosa L., Schoemaker M.H., Vrenken T.E., Buist-Homan M., Havinga R., Jansen P.L.M., and Moshage H. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J. Hepatol. 44 (2006) 918-929
34. Chieli E., and Malvadi G. Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology 31 (1984) 41-51
35. Hunter A.L., Holscher M.A., and Neal R.A. Thioacetamide induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. J. Pharmacol. Exp. Ther. 200 (1977) 439-448
36. Porter W.R., and Neal R.A. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab. Dispos. 6 (1978) 375-388
37. Benoit J.N., Grisham M.B., Mesh C.L., Korthuis R.J., and Granger D.N. Hepatic oxidant and antioxidant systems in portacaval-shunted rats. J. Hepatol. 14 (1992) 253-258
38. Sanz N., Diez-Fernandez C., Fernández-Simon L., Alvarez A., and Cháscales M. Necrogenic and regenerative responses of liver of newly weaned rats against a sublethal dose of thioacetamide. Biochim. Biophys. Acta 1384 (1998) 66-78
39. Lu S.C., Huang Z.Z., Yang H., and Tsukamoto H. Effect of thioacetamide on the hepatic expression of gamma-glutamylcysteine synthetase subunits in the rat. Toxicol. Appl. Pharmacol. 159 (1999) 161-168
40. Bruck R., Aeed H., Shirin H., et al. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure. J. Hepatol. 31 (1999) 27-38
41. Bruck R., Shirin H., Aeed H., Matas Z., Hochman A., Pines M., and Auni Y. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J. Hepatol. 35 (2001) 457-464
42. So E.C., Wong K.L., Huang T.C., Tasi S.C., and Liu C.F. Tetramethylpyrazine protects mice against thioacetamide induced acute hepatotoxicity. J. Biomed. Sci. 9 (2000) 410-414
43. Sanz N., Diez-Fernandez C., Andres D., and Cáscales M. Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18- and 30 months-old rats following a necrogenic dose of thioacetamide. Biochim. Biophys. Acta 1587 (2002) 17-20
44. Bruck R., Aeed H., Auni Y., Shirin H., Matas Z., Shahmurov M., Avinoach I., Zozulya G., Weixman N., and Hochman A. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J. Hepatol. 40 (2004) 86-93
45. Sarkar M.K., and Sil P.C. Hepatocytes are protected by herb Phyllantus nirui protein isolate against thioacetamide toxicity. Pathophysiology 14 (2007) 113-120
46. Lu P., Luo H.-S., Zhou X.-P., Paul S.C., Xiao Y.-J., Si X.-M., and Liu S.-Q. Thalidomide prevents rat liver cirrhosis inhibition of oxidative stress. Pathol. Res. Pract. 202 (2006) 777-788
47. Bomzon A., and Ljubuncic P. Oxidative stress and vascular smooth muscle cell function in liver disease. Pharmacol. Ther. 89 (2001) 295-308
48. Rodriguez-Villarrupla A., Bosch J., and Garcia-Pagan J.C. Potential role of antioxidants in the treatment of portal hypertension. J. Hepatol. 46 (2007) 193-197
49. Fernando B., Marley R., Holt S., Anand R., Harry D., Sanderson P., Smith R., Hamilton G., and Moore K. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 28 (1998) 689-694
50. Izzet T., Osman K., Ethem U., Nihat Y., Ramazan K., Mustafa D., Hafize U., Riza K.A., Birsen A., Habibe G., Seval A., and Gonul S. Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals. World J. Gastroenterol. 11 (2005) 3570-3573
51. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res. 93 (2003) 573-580
52. Liu Y, Li H, Bubolz AH, Zhang DX, Gutterman DD. Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles. Med Biol Eng Comput. 2008 Mar 14 [Epub ahead of print].
53. Prieto I., Jimenez F., Aller M.A., Nava M.P., Vara E., García C., and Arias J. Tumor necrosis factor-α, Interleukin-1β and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats. World J. Surg. 29 (2005) 903-908
54. Bradbury M.W., and Berk P.D. Lipid metabolism in hepatic steatosis. Clin. Liver Dis. 8 (2004) 639-671
55. Palma M.D., Aller M.A., Vara E., Nava M.P., García C., Arias-Diaz J., Balibrea J.L., and Arias J. Portal hypertension produces an evolutive hepato-intestinal pro- and anti-inflammatory response in the rat. Cytokine 31 (2005) 213-226
56. Schimpl G., Pesendorfer P., Steinwender G., Feierl G., Ratschek M., and Hollwarth M.E. Allopurinol reduces bacterial translocation, intestinal mucosal lipid peroxidation, and neutrophil-derived myeloperoxidase activity in chronic portal, hypertensive and common bile duct-ligated growing rats. Pediatr. Res. 40 (1996) 422-428
57. Pallottini V., Martini C., Basi A.M., Romano P., Nanni G., and Trentalance A. Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J. Hepatol. 44 (2006) 368-374
58. Schrader M., and Fahimi H.D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta 1763 (2006) 1755-1766
59. Reddy J.K., and Rao S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Gastrointest. Liver Physiol. 290 (2006) G852-G858
60. Yang S., Zhu H., Li Y., Lin H., Gabrielson K., Trush M.A., and Diehl A.M. Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 378 (2000) 259-268
61. Videla L.A., Rodrigo R., Araya J., and Poniachik J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol. Med. 12 (2006) 555-558
62. Videla L.A., Rodrigo R., Orellana M., Fernández V., Tapia G., Quiñones L., Varela N., Contreras J., Lazarte R., Sendes A., Rojas J., Maluenda E., Burdiles P., Diaz J.C., Smok G., Thielemann L., and Poniachick J. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. 106 (2004) 261-268
63. Kohjima M., Enjoji M., Higuchi N., Kato M., Coto K., Yoshimoto T., Fujino T., Yada M., Yada R., Harada N., Takayanagi R., and Nakamuta M. Re-evaluation of fatty acid metabolism-related gene expresión in non-alcoholic fatty liver disease. Int. J. Mol. Med. 20 (2007) 351-358
64. Leclercq I.A., Farrel G.C., and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111 (1996) 1645-1653
65. Lettéron P., Fromenty B., Terris B., Degott C., and Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol. 24 (1996) 200-208
66. Lebovitz R.M., Zhang H., Vogel H., Cartwright Jr. J., Dionne L., Lu N., Huang S., and Matzuk M.M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9782-9787
67. Suttorp N., Toepfer W., and Roka L. Antioxidant defense mechanisms of endothelial cells: glutathione redox cycle versus catalase. Am. J. Physiol. Cell Physiol. 251 (1986) C671-C680
68. 2. Arch. Biochem. Biophys. 210 (1981) 505-516